Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06550193 · ClinicalTrials.gov registry record · NA

Augmented Reality/Virtual Reality (AR/VR) for Ultrasound-guided Medical Procedures

A NA study, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target

NCT06550193: Recruiting NA study, sponsored by Stanford University.

NCT06550193 is a NA study that is actively recruiting participants, run by Stanford University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06550193, a NA study, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The study seeks to assess the efficacy of incorporating augmented reality (AR) or virtual reality (VR) technology into ultrasound-guided medical procedures such as regional anesthesia and line placement. By utilizing AR/VR devices, the investigators will improve the ergonomics when using ultrasound to guide procedures. The aims are to enhance visualization of anatomical structures and improve procedural accuracy for clinicians. The study aims to evaluate the feasibility, and effectiveness of integrating AR/VR technology into ultrasound-guided procedures, with the ultimate goal of improving patient outcomes.

Primary Outcome

Document the block result in pre-op, if feasible, or PACU by testing sensory (cold spray) and motor function on all nerves covered by the block

Interventions

  • DEVICE Ultrasound-guided procedure using AR/VR technology

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-09-30
Est. Completion 2027-12-31
Phase NA
Stanford University

1,744 total trials

What NCT06550193 shows while recruiting

NCT06550193 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Ultrasound-guided procedure using AR/VR technology is the first listed.

NCT06550193 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06550193 about?

NCT06550193 is a clinical study titled "Augmented Reality/Virtual Reality (AR/VR) for Ultrasound-guided Medical Procedures". The study seeks to assess the efficacy of incorporating augmented reality (AR) or virtual reality (VR) technology into ultrasound-guided medical procedures such as regional anesthesia and line placement. By utilizing AR/VR devices, the investigators will improve the ergonomics when using ultrasound ...

What is the current status of trial NCT06550193?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-09-30. Estimated completion is 2027-12-31.

What interventions are being tested in trial NCT06550193?

The interventions under investigation include: Ultrasound-guided procedure using AR/VR technology (DEVICE).

Who is sponsoring clinical trial NCT06550193?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06550193's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06550193, the US trial registry maintained by the National Library of Medicine. NCT06550193 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.